Form 4: Third Rock Ventures IV, L.P. Sells Shares of Tango Therapeutics, Inc.

Third Rock Ventures IV, L.P. sold 550,171 shares of Tango Therapeutics, Inc. at a weighted average price of $9.7903 on July 17, 2024.

Summary

• On July 17, 2024, Third Rock Ventures IV, L.P. sold 550,171 shares of Tango Therapeutics, Inc. common stock.
• The shares were sold at prices ranging from $9.75 to $10.00, with a weighted average price of $9.7903.
• Following the transaction, Third Rock Ventures IV, L.P. directly holds 18,651,304 shares of Tango Therapeutics, Inc.
• The general partners of Third Rock Ventures IV, L.P. are Third Rock Ventures GP IV, L.P. and TRV GP IV, LLC, who disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The sale of shares by a major holder could be interpreted in various ways, but without further context, it's neither definitively positive nor negative.

Industry Context

This Form 4 filing indicates a transaction by a major shareholder, Third Rock Ventures, a venture capital firm specializing in healthcare investments. Such transactions are common and are closely watched by investors for insights into the perspectives of significant stakeholders.

Stakeholder Impact

• The sale of shares by a major shareholder like Third Rock Ventures could potentially influence investor sentiment and the stock price of Tango Therapeutics.

Key Dates